Product Details
Place of Origin: China
Brand Name: BBCA
Certification: GMP
Model Number: BBCA18011530
Payment & Shipping Terms
Price: Negotiated
Packaging Details: 14 Tablets/box, 200 Boxes/Carton
Delivery Time: 25 DAYS AFTER PAYMENT
Payment Terms: L/C, T/T, , MoneyGram, L/C, T/T, , MoneyGram
Place Of Origin: |
China (Mainland) |
Brand Name: |
BBCA |
Other Names: |
Made In China Cilnidipine Tablets |
Grade: |
Medicine Grade |
Dosage Form: |
Injection |
Place Of Origin: |
China (Mainland) |
Brand Name: |
BBCA |
Other Names: |
Made In China Cilnidipine Tablets |
Grade: |
Medicine Grade |
Dosage Form: |
Injection |
Calcium Antagonists Cilnidipine Tablets 5mg 10mg To Treat Hypertension
Specifications
Cilnidipine Tablets
Type: Calcium Antagonists
Usage: Treatment for hypertension patients
Packing: 14TabletsX100Boxes/Carton
GMP Certified
Standard: 5mg
Original: China
Manufacture: ANHUI BBCA PHARMRACEUTICAL Co., Ltd.
Cilnidipine decreases blood pressure and is used to treat hypertension and its comorbidities. Due to its blocking action at the N-type and L-type calcium channel, cilnidipine dilates both arterioles and venules, reducing the pressure in the capillary bed. Cilnidipine is vasoselective and has a weak direct dromotropic effect, a strong vasodepressor effect, and an arrhythmia-inhibiting effect. Blood pressure control with cilnidipine treatment in Japanese post-stroke hypertensive patients - the results of a large-scale prospective post-marketing surveillance study of post-stroke hypertensive patients (n = 2667, male 60.4%, 69.0 ± 10.9 years) treated with cilnidipine indicate that ilnidipine was effective in treating uncontrolled blood pressure and was well tolerated in post-stroke hypertensive patients.The Ambulatory Blood Pressure Control and Home Blood Pressure (Morning and Evening) Lowering By N-Channel Blocker Cilnidipine trial is a large-scale (n=2319) clinical study on blood pressure (BP) and pulse rate (PR) in the real world with use of cilnidipine - this study revealed that Cilnidipine significantly reduced BP and PR in hypertensive patients at the clinic and at home, especially with higher BP and PR in the morning.
